Opportunities for More Tailored Approaches to Genotoxicity Testing and Carcinogenicity Strategy for Oligonucleotide Therapeutics: Outcome of an Industry Survey.
Parry JD, Harper TA Jr, Andersson P, Elloway JM, Holman NS, Achanzar WE, Lynch A, Tessier Y, Crosby M, Floettmann E, Coeffet M, Guérard M, Cnubben NHP, Irrechukwu ON, Wattrelos O, Yang Y.
Parry JD, et al. Among authors: yang y.
Nucleic Acid Ther. 2025 Jan 23. doi: 10.1089/nat.2024.0075. Online ahead of print.
Nucleic Acid Ther. 2025.
PMID: 39846858